Search Results for: BIIB
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues. Next quarter estimates are $0.86...
Published:
All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a friendly merger. The first discussions noted by the WSJ were...
Published:
Last Updated:
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We do not want to try to sound as though this TYSABRI news is something that...
Published:
Last Updated:
These are some of the top pre-market upgrades from analysts which we have seen in the early hours this Monday morning: Acorda Therapeutics (ACOR) Raised to Outperform at Baird. Biogen Idec (BIIB)...
Published:
Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend. We are focusing solely on the biotech,...
Published:
Last Updated:
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had enjoyed an...
Published:
Last Updated:
We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that the November-end NASDAQ Short Interest has been released, we wanted to see how the...
Published:
These are some of the top analyst upgrades and positive research calls we have seen from Wall Street analysts with more than two hours until the market opens this Tuesday morning: ARM Holdings (ARMH)...
Published:
Last Updated:
Active traders and day traders have several key stocks to watch. We are tracking moves in Adobe Systems, Inc. (NASDAQ: ADBE), Biogen Idec Inc. (NASDAQ: BIIB), Deutsche Bank AG (NYSE: DB), Microsoft...
Published:
Last Updated:
We have many stocks on the move this morning. Our top pre-market movers for active traders and day traders alike are Apollo Group Inc. (NASDAQ: APOL), Barclays PLC (NYSE: BCS), Royal Bank of...
Published:
Last Updated:
Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion. This will also mark the end of the fiscal...
Published:
Last Updated:
These are some of the key analyst downgrades and negative analyst calls we have seen early this Monday morning with over 2 hours to open: Biogen Idec (BIIB) Cut to Sell at Banc of America. Cbeyond...
Published:
When corporate management and insiders unload shares of stock, investors often look at the transactions. This is legal insider trading that generally comes from planned share sales and/or via the...
Published:
Last Updated:
Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This data showed that Fampridine, which is designed...
Published:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated: